Astaxanthin inhibits gemcitabine-resistant human pancreatic cancer progression through EMT inhibition and gemcitabine resensitization

Pancreatic cancer rapidly acquires resistance to chemotherapy resulting in its being difficult to treat. Gemcitabine is the current clinical chemotherapy strategy; however, owing to gemcitabine resistance, it is only able to prolong the life of patients with pancreatic cancer for a limited number of...

Descripción completa

Detalles Bibliográficos
Autores principales: Yan, Tao, Li, Hai-Ying, Wu, Jian-Song, Niu, Qiang, Duan, Wei-Hong, Han, Qing-Zeng, Ji, Wang-Ming, Zhang, Tao, Lv, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2017
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5652142/
https://www.ncbi.nlm.nih.gov/pubmed/29098031
http://dx.doi.org/10.3892/ol.2017.6836

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5652142/
https://www.ncbi.nlm.nih.gov/pubmed/29098031
http://dx.doi.org/10.3892/ol.2017.6836

Ejemplares similares